CAS 1819986-22-5

Fórmula: C30H44N2O14

InChI: InChI=1S/C30H44N2O14/c33-25(31-13-3-5-23(31)27(35)41-19-43-29(37)45-21-9-15-39-16-10-21)7-1-2-8-26(34)32-14-4-6-24(32)28(36)42-20-44-30(38)46-22-11-17-40-18-12-22/h21-24H,1-20H2/t23-,24-/m1/s1

Clave InChI: KSKLDMGKWDUQCT-DNQXCXABSA-N

SMILES: C1C[C@@H](N(C1)C(=O)CCCCC(=O)N2CCC[C@@H]2C(=O)OCOC(=O)OC3CCOCC3)C(=O)OCOC(=O)OC4CCOCC4

amyloid P-IN-1

CAS: 1819986-22-5

amyloid P-IN-1

Fórmula: C₃₀H₄₄N₂O₁₄

Pureza: ≥98%

Peso molecular: 656.68

Ref: 54-BUP09836

amyloid P-IN-1

CAS: 1819986-22-5

Fórmula: C₃₀H₄₄N₂O₁₄

Peso molecular: 656.6754

Ref: IN-DA00ABRW

amyloid P-IN-1

CAS: 1819986-22-5

Bis(((((tetrahydro-2H-pyran-4-yl)oxy)carbonyl)oxy)methyl) adipoyl(R)-di-D-prolinate

Fórmula: C₃₀H₄₄N₂O₁₄

Pureza: 98+%

Peso molecular: 656.68

Ref: IN-DG764762

amyloid P-IN-1

CAS: 1819986-22-5

Amyloid P-IN-1 is a ligand that binds to the amyloid peptide and inhibits the formation of amyloids. Amyloid P-IN-1 has been shown to be an orally active molecule in humans, with a low oral bioavailability due to its physicochemical properties. The affinity for amyloid P-IN-1 to bind to the amyloid peptide is high and it has been shown to inhibit the growth of amyloids in vitro and in vivo. Amyloid P-IN-1 also has pharmacological effects on ligands, such as binding to receptors on cells, which may account for its potential use as a therapeutic agent.

Fórmula: C₃₀H₄₄N₂O₁₄

Pureza: Min. 95%

Peso molecular: 656.68 g/mol

Ref: 3D-UXC98622

amyloid P-IN-1

CAS: 1819986-22-5

amyloid P-IN-1 can be used in studies about diseases with depletion of serum amyloid P components such as Alzheimer's disease, amyloidosis, osteoarthritis, and

Fórmula: C₃₀H₄₄N₂O₁₄

Pureza: 99.76%

Forma y color: Solid

Peso molecular: 656.68

Ref: TM-T14283